Latest Updates

On December 6th, the Senate Finance Committee released an updated bipartisan version of S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA), and included language to require pharmacy price concessions be included in negotiated price at the point of sale for Medicare Part D beginning in 2022. This language would also prohibit retroactive DIR fees and would allow positive post point-of-sale incentive payments for pharmacies in addition to establishing pharmacy quality metrics in 2022.

In honor of American Pharmacists Month, Chain Drug Review featured Steve Hoffart of Magnolia Pharmacy, a Good Neighbor Pharmacy, in its “Excellence in Pharmacy Practice” section: Independent makes a major difference in rural location.

Drug Store News recognized Good Neighbor Pharmacy and Elevate Provider Network’s very own superstars, Chris and Mindy Munden of Hemmingsen Drug Store, who go above and beyond to remain independent and deliver unmatched care and service for their patients. Serving on both the Good Neighbor Pharmacy and Elevate Provider Network Advisory Boards, Chris also works to help ensure the success of Elevate members and independent community pharmacy. Hemmingsen Drug Store was a finalist in the Good Neighbor Pharmacy of the Year award for 2019, proving that the kind of care the Mundens provide is highly valued in their community and has earned them a loyal patient base.

With the U.S. Congress on recess until October 14th, now is the perfect time to reach out and advocate for critical issues impacting your pharmacy. Access resources to aid you in the process of advocating for your pharmacy.

With most of the 2019 state legislative sessions complete, state lawmakers are beginning to look toward legislative priorities for 2020, including new drug pricing legislation.